You have 9 free searches left this month | for more free features.

City

Beijing (1)

Changchun (1)

Condition

Glucocorticoid Induced Osteoporosis (1)

Hypercalcemia of Malignancy (1)

Postmenopausal Osteoporosis (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Shanghai JMT-Bio Inc. (3)

Collaborator

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)

Intervention

jmt103 (3)

alendronate sodium (1)

alendronate sodium placebo (1)

denosumab (1)

jmt103 placebo (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

jmt103

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Glucocorticoid Induced Osteoporosis Trial in Beijing (JMT103, Alendronate sodium, JMT103 )

Not yet recruiting

Glucocorticoid Induced Osteoporosis

JMT103
+3 more

Beijing, Beijing, China

Peking University First Hospital

May 25, 2022

Postmenopausal Osteoporosis Trial in Changchun (JMT103, Denosumab, Placebo)

Recruiting

Postmenopausal Osteoporosis

JMT103
+2 more

Changchun, Jilin, China

The Second Hospital of Jilin University

Jul 14, 2022

Hypercalcemia of Malignancy Trial (JMT103)

Unknown status

Hypercalcemia of Malignancy

JMT103

(no location specified)

Dec 11, 2019